News & Events

Shehnaz Kataria, Chief Financial Officer, Appointed to StageBio

StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is pleased to welcome Shehnaz Kataria to the executive team as Chief Financial Officer.

How to De-Risk Your Nonclinical Study and Optimize Outcomes

Anyone developing study protocols and study design knows that components of a thorough safety assessment vary due to any number of factors.

StageBio Announces new Head of Commercial, Wendy Sauer

Wendy Sauer joins StageBio as Head of Commercial

StageBio Announces new Director of Human Resources, Jennifer Nelson

Jennifer Nelson joins StageBio as Director of Human Resources

StageBio Attends STP’s 43rd Annual Symposium

Join StageBio at the 43rd STP Symposium, June 16-19 in Baltimore. Explore innovative therapeutics and attend our CE course on immunotoxicology with Dr. Papenfuss.

Meet our featured StageBio pathologist, Dr. Lisa Mangus!

Meet our featured StageBio senior pathologist, Dr. Lisa Mangus, DVM, PhD, DACVP!

Meet our featured StageBio pathologist, Dr. Olivia Patania!

Meet our featured StageBio pathologist, Dr. Olivia Patania, DVM, PhD, DACVP!

Dr. Stephanie Shrader Named Vice President of Pathology Solutions with StageBio

StageBio is excited to celebrate Dr. Stephanie Shrader in her new position as Vice President of Pathology Solutions.

Pathologist Spotlight: Meet Dr. Joy Gary

Meet our featured StageBio pathologist, Dr. Joy Gary DVM, PhD, DACVP, Senior Pathologist/Principal Investigator, Neuropathology

StageBio Announces David Bruning as New CEO & President

StageBio is delighted to announce that David Bruning is joining our team as our new CEO and President.

Upcoming Events

CONFERENCES

ESTP

Date: August 28-31
Location: Madrid, Spain

EuroTox

Date: Sept 8-11
Location: Copenhagen, Demark

Learn more about StageBio’s COVID-19 response